These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 11570261

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Effect of single-using or combined-using lamivudine/interferon-alpha 1b on serum markers in patients with hepatitis B].
    Yan J, Zhang LS, Zhao XK.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):109-10. PubMed ID: 12648410
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Hepatitis C Virus in the HIV-infected patient.
    Andersson K, Chung RT.
    Clin Liver Dis; 2006 May; 10(2):303-20, viii. PubMed ID: 16971263
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Providers face big challenge: HIV/HCV co-infection. Hepatitis B infection also problematic.
    AIDS Alert; 2006 Aug; 21(8):85-7. PubMed ID: 16913040
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, Nacca C, Sagnelli C, De Stefano G, Ferraro T, De Stefano C, Sagnelli E.
    AIDS; 2006 Jun 12; 20(9):1253-60. PubMed ID: 16816553
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
    Hopf U, Niederau C, Kleber G, Fleig WE.
    Z Gastroenterol; 1997 Nov 12; 35(11):971-86. PubMed ID: 9490556
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep 12; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ribozymes as antiviral agents.
    Bartolomé J, Castillo I, Carreño V.
    Minerva Med; 2004 Feb 12; 95(1):11-24. PubMed ID: 15041923
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
    Bani-Sadr F.
    Gastroenterol Clin Biol; 2003 May 12; 27(5):528-33. PubMed ID: 12843917
    [No Abstract] [Full Text] [Related]

  • 40. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT.
    Top HIV Med; 2005 May 12; 13(4):112-6. PubMed ID: 16304454
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.